Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0001209191-21-049938 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-05 | 2021-08-03 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +4,700 | 4,700 | New | $0 |
| D | 2021-08-05 | 2021-08-03 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +21.7K | 21.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | A | A | 4,700 | $0.00 | 4,700 | D | — | — | (F1) Represents the grant of restricted stock units that vest in three equal annual installments on each of September 15, 2022, September 15, 2023, and September 15, 2024, subject to the Reporting Person's continued service to the Company. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-08-03 | A | A | 21,700 | $0.00 | 21,700 | D | $30.02 · — to 2031-08-02 | 21,700 Common Stock | (F2) The option is exercisable in 36 equal monthly installments after August 3, 2021, subject to the Reporting Person's continued service to the Company. |